Published March 2018
| Version v1
Journal article
Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative
Creators
- 1. Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland (United States)
- 2. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York (United States)
- 3. Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa (United States)
- 4. Department of Radiation Oncology, University of Louisville, Louisville (United States)
- 5. Department of Radiation Oncology, Henry Ford Health System, Detroit (United States)
Description
The therapeutic ratio of reirradiation for recurrent or second primary (RSP) squamous carcinoma of the head and neck may be improved in the intensity modulated radiation therapy (IMRT) era. However, patient selection for reirradiation remains challenging. We performed a multi-institution cohort study to investigate modern outcomes after IMRT-based reirradiation and to identify prognostic subgroups.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2017.06.012Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2017.06.012;
- PII
- S0360301617310611;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 100
- Journal Issue
- 3
- Journal Page Range
- p. 586-594
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 52123575
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; HEAD; NECK; PATIENTS; RADIOTHERAPY
- Descriptors DEC
- BODY; DISEASES; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; RADIOLOGY; THERAPY
Optional Information
- Copyright
- Copyright (c) 2017 Elsevier Inc. All rights reserved.